论文部分内容阅读
In recent years, cancer immunotherapy, one of the most promising ways for the treatment of cancer, has been widely developed.1,2 However, it is very hard to construct a wide antigenadaptive, easy-handling, biodegradable system which can recruit and activate antigen presenting cells (APCs).